Scott; Terrence L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Scott; Terrence L..The latest application filed is for "delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes".

Company Profile

0.9.15

Scott; Terrence L. - Winchester MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes Grant 9,115,357 - Brown , et al. August 25, 2	2015-08-25
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation Grant 8,075,919 - Brown , et al. December 13, 2	2011-12-13
Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes Grant 7,884,085 - Brown , et al. February 8, 2	2011-02-08
Nucleic acid microspheres, production and delivery thereof Grant 7,815,941 - Brown , et al. October 19, 2	2010-10-19
Delivery Of As-oligonucleotide Microspheres To Induce Dendritic Cell Tolerance For The Treatment Of Autoimmune Type 1 Diabetes App 20100260855 - Brown; Larry R. ; et al.	2010-10-14
Non-covalent modification of microparticles and process of preparing same App 20100009007 - Darvari; Ramin ; et al.	2010-01-14
Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same App 20080248122 - Rashba-Step; Julia ; et al.	2008-10-09
Pulmonary Delivery Of Spherical Insulin Microparticles App 20080026068 - Brown; Larry R. ; et al.	2008-01-31
Methods For Fabrication, Uses, Compositions Of Inhalable Spherical Particles App 20070092452 - Rashba-Step; Julia ; et al.	2007-04-26
Surface-modified Microparticles And Methods Of Forming And Using The Same App 20060260777 - Rashba-Step; Julia ; et al.	2006-11-23
Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes App 20060024240 - Brown; Larry R. ; et al.	2006-02-02
Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation App 20050233945 - Brown, Larry ; et al.	2005-10-20
Methods for encapsulating small spherical particles prepared by controlled phase separation App 20050170005 - Rashba-Step, Julia ; et al.	2005-08-04
Methods for fabrication, uses and compositions of small spherical particles of AAT prepared by controlled phase separation App 20050147687 - Rashba-Step, Julia ; et al.	2005-07-07
Methods for encapsulating small spherical particles prepared by controlled phase separation App 20050142205 - Rashba-Step, Julia ; et al.	2005-06-30
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation App 20050142206 - Brown, Larry ; et al.	2005-06-30
Methods for fabrication, uses and compositions of small spherical particles of hGH prepared by controlled phase separation App 20050142201 - Rashba-Step, Julia ; et al.	2005-06-30
Propellant-based microparticle formulations App 20030064033 - Brown, Larry R. ; et al.	2003-04-03
Sustained release microspheres App 20030059474 - Scott, Terrence L. ; et al.	2003-03-27
Sustained release microspheres Grant 6,458,387 - Scott , et al. October 1, 2	2002-10-01
Macromolecular microparticles and methods of production and use Grant 6,268,053 - Woiszwillo , et al. July 31, 2	2001-07-31
Macromolecular microparticles and methods of production and use Grant 6,090,925 - Woiszwillo , et al. July 18, 2	2000-07-18
Macromolecular microparticles and methods of production and use Grant 5,981,719 - Woiszwillo , et al. November 9, 1	1999-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.